Skip to main content
Cystic fibrosis transmembrane conductance regulator modulator administration to a F508del heterozygous infant with meconium pseudocyst and short bowel syndrome: A case report.
Prostaglandin-E1 infusion in persistent pulmonary hypertension of the newborn.
How Many Billions Is Enough? Prioritizing Profits Over Patients With Cystic Fibrosis.
Sociodemographic factors associated with tracheostomy and mortality in bronchopulmonary dysplasia.
Pulmonary hypertension is an important co-morbidity in developmental lung diseases of infancy: Bronchopulmonary dysplasia and congenital diaphragmatic hernia.
Association of patient weight status with plasma surfactant protein D, a biomarker of alveolar epithelial injury, in children with acute respiratory failure.
The many faces and outcomes of pulmonary vein stenosis in early childhood.
Respiratory medication use in extremely premature (<29 weeks) infants during initial NICU hospitalization: Results from the prematurity and respiratory outcomes program.
Outcomes of pulmonary vascular disease in infants conceived with non-IVF fertility treatment and assisted reproductive technologies at 1 year of age.
Regional variations in longitudinal pulmonary function: A comparison of Hispanic and non-Hispanic subjects with cystic fibrosis in the United States.